Enzastaurin for the treatment of cancer

Details Enzastaurin for the treatment of cancer Enzastaurin for the treatment of cancer

A - Human Necessities

61

K

A61K 31/4545 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2746085

The present invention relates to HDAC2 as a biological marker for treating cancer in a patient using Enzastaurin as a single agent or in combination with a Class I selective HDAC inhibitor.

La présente invention concerne HDAC2 en tant que marqueur biologique dans le traitement du cancer chez un patient utilisant l'Enzastaurine en monothérapie ou en association avec un inhibiteur sélectif de HDAC de Classe I.

Affiliated with

Also associated with

Rating

Enzastaurin for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzastaurin for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzastaurin for the treatment of cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1693929